The latest price target for Mesoblast (NASDAQ:MESO) was reported by Jefferies on December 23, 2024. The analyst firm set a price target for $0.00 expecting MESO to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Mesoblast (NASDAQ:MESO) was provided by Jefferies, and Mesoblast downgraded their hold rating.

The last upgrade for Mesoblast Ltd happened on September 24, 2024 when Maxim Group raised their price target to $12. Maxim Group previously had a hold for Mesoblast Ltd.

The last downgrade for Mesoblast Ltd happened on December 23, 2024 when Jefferies changed their price target from N/A to N/A for Mesoblast Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesoblast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesoblast was filed on December 23, 2024 so you should expect the next rating to be made available sometime around December 23, 2025.

While ratings are subjective and will change, the latest Mesoblast (MESO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Mesoblast (MESO) is trading at is $19.20, which is out of the analyst’s predicted range.